HUTCHMED (China) Ltd SEC filings HMDCF
HUTCHMED (China) Ltd has 611 filings in SEC EDGAR's recent list, going back to Aug 21, 2015. Its latest annual report, Form 20-F, was filed on Mar 5, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Nov 5, 2026.
| Form | Description | Filed | Period |
|---|---|---|---|
| 4 | Insider transaction | May 21, 2026 | May 20, 2026 |
| 4 | Insider transaction | May 21, 2026 | May 20, 2026 |
| 4 | Insider transaction | May 21, 2026 | May 20, 2026 |
| 4 | Insider transaction | May 21, 2026 | May 20, 2026 |
| 4 | Insider transaction | May 13, 2026 | May 12, 2026 |
| 3 | Initial insider ownership | Mar 31, 2026 | Mar 31, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 16, 2026 | Mar 16, 2026 |
| 3 | Initial insider ownership | Mar 11, 2026 | Mar 11, 2026 |
| 3 | Initial insider ownership | Mar 10, 2026 | Mar 10, 2026 |
| 3 | Initial insider ownership | Mar 10, 2026 | Mar 10, 2026 |
| 3 | Initial insider ownership | Mar 10, 2026 | Mar 10, 2026 |
| 3 | Initial insider ownership | Mar 10, 2026 | Mar 10, 2026 |
| 3 | Initial insider ownership | Mar 10, 2026 | Mar 10, 2026 |
| 3 | Initial insider ownership | Mar 10, 2026 | Mar 10, 2026 |
| 3 | Initial insider ownership | Mar 10, 2026 | Mar 10, 2026 |
| 3 | Initial insider ownership | Mar 10, 2026 | Mar 10, 2026 |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 13, 2023 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 11, 2022 | — |
| SC 13D/A | Amended ownership over 5% (active) | Feb 7, 2022 | — |
| SC 13D | Ownership over 5% (active) | Aug 16, 2021 | — |
| SC 13D/A | Amended ownership over 5% (active) | Jul 1, 2021 | — |
| SC 13D/A | Amended ownership over 5% (active) | Jun 30, 2021 | — |
| SC 13D/A | Amended ownership over 5% (active) | Apr 13, 2021 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 16, 2021 | — |
| SC 13D/A | Amended ownership over 5% (active) | Nov 27, 2020 | — |
| SC 13D/A | Amended ownership over 5% (active) | Jul 7, 2020 | — |
| SC 13D | Ownership over 5% (active) | Jul 6, 2020 | — |
| SC 13G | Ownership over 5% (passive) | Feb 14, 2020 | — |
| SC 13D/A | Amended ownership over 5% (active) | Jan 29, 2020 | — |
| SC 13D/A | Amended ownership over 5% (active) | Sep 30, 2019 | — |
| SC 13D/A | Amended ownership over 5% (active) | Jul 2, 2019 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 13, 2018 | — |
| SC 13D | Ownership over 5% (active) | Nov 9, 2017 | — |
| SC 13G | Ownership over 5% (passive) | Feb 13, 2017 | — |
| SC 13G | Ownership over 5% (passive) | Feb 8, 2017 | — |
Showing 36 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- HCM (Nasdaq), HMDCF (OTC)
- Incorporated in
- Cayman Islands
- Headquarters
- Hong Kong
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1648257
- Former names
- Hutchison China MediTech Ltd (until Apr 29, 2021)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.